Diyong Xu

Insider Reports History

Location
601 Lexington Ave., 54 Th Floor, New York, NY
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Diyong Xu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. Director Stock Option (Right to Buy) 53.5K $171K $13.42 Oct 23, 2025 Direct

Insider Reports Filed by Diyong Xu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Q32 Bio Inc. Oct 23, 2025 1 $0 4 Oct 27, 2025 Director
QTTB Q32 Bio Inc. Feb 24, 2025 2 $0 4 Feb 26, 2025 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director, 10%+ Owner
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director, 10%+ Owner